23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.
Seven directors of 23andMe resigned from the genetic test company's board Tuesday amid co-founder and CEO Anne Wojcicki's attempt to buy out existing ... "After months of work, we have yet to ...
In a memo to employees, CEO Anne Wojcicki said she was "surprised and disappointed by the decision." All seven independent directors of 23andMe resigned from the company's board Tuesday ...
In a letter sent to co-Founder, Chief Executive and Chair of the board Anne Wojcicki, the directors said the decision comes after months of work that ... sought to build out the company's core ...
On Tuesday, the independent directors of the Board of 23andMe Holding Co. (NASDAQ:ME) sent a letter to Anne Wojcicki ... “After months of work, we have yet to receive from you a fully financed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback